Drug · CHEMBL532
ERYTHROMYCIN
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. ERYTHROMYCIN. Drugs and targets, record CHEMBL532. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL532
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Brand names
A/t/s, Akne-mycin, Aknemycin plus, C-solve-2, E-base, E-glades, E-mycin, E-solve 2, Emgel, Ery-tab, Eryacne 2, Eryacne 4, Eryc, Eryc 125, Eryc sprinkles, Erycette, Eryderm, Erygel, Erymax, Erymax sprinkle, Erythra-derm, Erythro 200, Erythro-statin, Erythromycin component of aktipak, Erythromycin component of benzamycin, Gallimycin, Ilotycin, Isotrexin, Kerymax, Oftalmolosa cusi eritromicina, Paediathrocin, Pce (erythromycin), R-p mycin, Retcin, Robimycin, Rommix 250 ec, Rommix 500 ec, Sansac, Staticin, Stiemycin, T-stat, Tiloryth, Zineryt
- ChEMBL
- Other names
- Eritromicina, Erythromycin estolate impurity, free erythromycin-, Erythromycine, J01FA01, NSC-55929
- ChEMBL
- Open Targets' highest stage
- Approval, for 6 of its 36 diseases, from ATC, DailyMed and TTD
- Open Targets
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases36
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
1 to 10 of 36Source Open Targets
See all 36 diseasesTrials81
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT00718315 | A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. | Phase 3 | 201 | 2015-01-15 | erythromycin | Its name | ClinicalTrials.gov |
| NCT02481219 | Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure | 122 | 2016-07-11 | erythromycin | Its name | ClinicalTrials.gov | |
| NCT01379183 | Using Magnetic Resonance (MR) to Understand the Effect of Erythromycin on Bowel Motility | Phase 2/3 | 40 | 2014-01-27 | erythromycin | Its name | ClinicalTrials.gov |
| NCT01478256 | Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis | Phase 4 | 30 | 2013-11-20 | erythromycin | Its name | ClinicalTrials.gov |
| NCT00304187 | Effectiveness of Antibiotic Treatment for Reducing Binge Eating and Improving Digestive Function in Bulimia Nervosa | Phase 2 | 29 | 2013-07-30 | erythromycin | Its name | ClinicalTrials.gov |
| NCT03480243 | Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil | Phase 1 | 28 | 2021-07-12 | erythromycin | Its name | ClinicalTrials.gov |
| NCT01323582 | Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis | Phase 2 | 26 | 2014-12-05 | erythromycin | Its name | ClinicalTrials.gov |
| NCT03060473 | Treatment of ppROM With Erythromycin vs. Azithromycin Trial | Phase 3 | 21 | 2024-06-25 | erythromycin | Its name | ClinicalTrials.gov |
| NCT00589329 | Antibiotics and the Prolongation of Pregnancy in Preterm Labor With an Advanced Cervical Exam | 20 | 2019-09-04 | erythromycin | Its name | ClinicalTrials.gov | |
| NCT02005029 | Erythromycin in Parkinson's Disease | 18 | 2017-02-03 | erythromycin | Its name | ClinicalTrials.gov |
1 to 10 of 81
See all 81 trialsComparisons in its trials10
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Bowel Preparation Regimen -Control vs Bowel Preparation Regimen-Test: serious adverse events | 0 of 59 | 1 of 62 | 121 | NCT02481219 | Trial comparisons |
| Erythromycin vs Azithromycin: serious adverse events | 0 of 26 | 0 of 26 | 52 | NCT01323582 | Trial comparisons |
| Erythromycin vs Placebo: serious adverse events | 0 of 20 | 0 of 20 | 40 | NCT01379183 | Trial comparisons |
| Besifloxocin vs Erythromycin: Improvement in Signs and Symptoms of Blepharitis | 15 of 15 | 15 of 15 | 30 | NCT01478256 | Trial comparisons |
| Besifloxocin vs Erythromycin: Evaluate Improvement of Bacterial Cultures With Two Different Topical Antibiotics | 15 of 15 | 15 of 15 | 30 | NCT01478256 | Trial comparisons |
| Besifloxocin vs Erythromycin: serious adverse events | 0 of 15 | 0 of 15 | 30 | NCT01478256 | Trial comparisons |
| Erythromycin vs Placebo: serious adverse events | 0 of 15 | 0 of 14 | 29 | NCT00304187 | Trial comparisons |
| Group A vs Group B: Respiratory Distress | 2 of 10 | 1 of 10 | 20 | NCT00589329 | Trial comparisons |
| Group A vs Group B: serious adverse events | 0 of 10 | 0 of 10 | 20 | NCT00589329 | Trial comparisons |
| Erythromycin vs Placebo: serious adverse events | 0 of 9 | 0 of 10 | 19 | NCT02005029 | Trial comparisons |
Papers from its trials23
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL532
GET https://conductscience.org/api/drugs/v1/CHEMBL532/diseases?page=2